BIO Issues Call for Breakout Session Proposals for 2007 BIO International Convention

WASHINGTON, D.C. (July 7, 2006) – The Biotechnology Industry Organization (BIO) invites leaders in the spheres of science, finance, business, law, and government policy to submit proposals for breakout sessions at the BIO International Convention, to be held May 6-9, 2007, at the Boston Convention and Exhibition Center.

The BIO International Convention continues to be the number one resource for the latest information and the newest opportunities for executives, investors, scientists, policy leaders, and journalists from around the world. Speakers at the sessions will share breakthroughs in medicine, diagnostics, the environment, energy production, food and agriculture, and more with a global audience of more than 19,000 attendees.

Applications for educational sessions will only be accepted online, at The online application opens today and closes on Monday, August 21, 2006.

The convention will feature more than 180 breakout sessions in 20 educational session tracks, including biodefense; bioethics; clinical research/clinical trials; devices and diagnostics; drug discovery and development; emerging company issues; finance; food and agriculture; industrial and environmental; intellectual property/legal; manufacturing; nanotechnology; technology transfer/licensing and other key business areas for doing biotech business globally.

All proposals will be reviewed by BIO staff, the standing BIO Program Committee and a local Program Committee composed of biotechnology professionals. Applicants will be notified of the status of their session proposal beginning late September 2006.

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products.